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Abstract
Colon carcinoma and melanoma cells containing either a deletion of the adenomatous polyposis coli tumor suppressor
protein (APC) or mutation of the site in L-catenin phosphorylated by glycogen synthase kinase-3L (GSK-3L) display elevated
levels of detergent-soluble L-catenin due to insensitivity of the cytosolic protein to proteasome-dependent degradation. In this
study, we have examined the effect of L-catenin mutation (S37F) or APC loss on the proteasome sensitivity of additional
subcellular L-catenin pools in melanoma cells. In contrast to detergent-soluble L-catenin, the detergent-insoluble protein
remains proteasome-sensitive irrespective of S37F mutation or APC status. This insoluble component appears associated
primarily with nuclear cytoskeletal elements. In addition, DNase I treatment solubilized a portion of detergent-insoluble
L-catenin, suggesting that this fraction also contains chromatin-associated protein, and correlating with a proteasome-
sensitive elevation in L-catenin-stimulated reporter activity. Since the detergent-insoluble nuclear component of L-catenin
displays GSK-3L- and APC-independent proteasome sensitivity, distinct from the soluble nuclear and cytosolic pools of this
protein, regulation of L-catenin proteasome sensitivity and the contribution of this process to L-catenin function may be
more complex than previously appreciated. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: L-Catenin; Melanoma; Proteasome; Nuclear cytoskeleton
1. Introduction
L-Batenin is a multifunctional protein which plays
an important role in both cell^cell interactions [1,2]
and growth factor signal transduction [3]. In normal
epithelial cells, L-catenin associates primarily with
the cytoplasmic domain of the calcium-dependent,
trans-membrane adhesion molecules N- and E-cad-
herin, which have been shown to participate in for-
mation of stable cell^cell contacts [4,5]. Through hy-
drophobic association with K-catenin [6,7], L-catenin
mediates the interaction between cadherin and the
actin cytoskeleton [8^10].
The balance between the L-catenin membrane
pool, involved in cadherin-mediated cell^cell contact,
and the cytoplasmic pool, important for signal trans-
duction, is ¢nely regulated by the opposing actions
of the adenomatous polyposis coli tumor suppressor
protein (APC) and the Drosophila wingless homo-
logue gene Wnt-1. Although cadherin-bound L-cate-
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nin appears resistant to proteasome degradation,
soluble, monomeric L-catenin is a proteasome sub-
strate [11,12]. The serine/threonine kinase glycogen
synthase kinase-3L (GSK-3L) recognizes L-catenin
complexed to APC, and GSK-3L-mediated phos-
phorylation of L-catenin subsequently targets L-cat-
enin for proteasomal degradation [13,14]. Mutational
analyses have demonstrated that a GSK-3L phos-
phorylation site is necessary for degradation of solu-
ble L-catenin by the 26S proteasome [15]. Likewise,
detergent-soluble L-catenin steady-state level has
been found to be elevated in cells lacking functional
APC protein [14,16,17]. Finally, activation of Wnt
induces an inhibitory phosphorylation of GSK-3L
which in turn blocks its ability to phosphorylate
L-catenin, resulting in L-catenin stabilization.
Stabilization of L-catenin by any of these mecha-
nisms results in a selective increase in the amount of
uncomplexed, monomeric L-catenin [15,18,19], which
accumulates in the cytoplasm and translocates to the
nucleus [20]. By associating with transcription factors
of the LEF/TCF family, nuclear-localized L-catenin
modulates transcription of several LEF/TCF-respon-
sive genes [21^24]. Recent studies suggest that inap-
propriate modulation of gene transcription by L-cat-
enin^LEF/TCF complexes may play a pivotal role in
tumor progression [14,25^33].
Although both deletion of APC and S37F muta-
tion of L-catenin result in the inhibition of protea-
some-dependent degradation of the soluble compo-
nent of this protein, little is known of the e¡ect of
these mutations/deletions on the proteasome sensitiv-
ity of other subcellular pools of L-catenin. To ad-
dress this question, we have examined the protea-
some sensitivity of detergent-soluble and -insoluble
fractions of L-catenin in three previously described
melanoma cell lines: one which contains wild type
L-catenin and APC, one which contains wild type
L-catenin but lacks APC, and one which expresses
wild type APC together with an S37F mutated L-
catenin [17]. We found that the detergent-insoluble
fraction of L-catenin, in contrast to the detergent-
soluble pool, retained proteasome sensitivity which
was independent of either APC status or the presence
of an intact GSK-3L phosphorylation site. Further-
more, this detergent-insoluble L-catenin pool consti-
tuted a signi¢cant percentage of total cellular L-cat-
enin following proteasome inhibition, and we found
it to be associated primarily with nuclear cytoskeletal
elements and chromatin. These data suggest that reg-
ulation of the proteasome sensitivity of L-catenin and
the contribution of this process to L-catenin function,
particularly in the nucleus, may be more complex
than previously appreciated.
2. Materials and methods
2.1. Reagents and drugs
Culture media were purchased from Bio£uids, Inc.
The proteasome inhibitor ALLnL (N-acetyl-L-leucyl-
L-leucyl-L-norleucinal) was purchased from Sigma
Chemical Co. Lactacystin was purchased from Bio-
mol. Anti-L-catenin monoclonal antibody was pur-
chased from Santa Cruz Biotechnology, Inc. Rabbit
anti-mouse IgG1 was obtained from Cappel, and
horseradish peroxidase-conjugated sheep anti-mouse
antibody was purchased from Amersham Life Sci-
ence. Protein A-Sepharose beads were purchased
from Pharmacia. BCA protein assay reagent and
Western blot chemiluminescence reagents were pur-
chased from Pierce Chemical Co. Protran nitrocellu-
lose membranes were obtained from Schleicher and
Schuell. All the other chemicals used in this study
were purchased from Sigma Chemical Co.
2.2. Cell culture
The melanoma cell lines 1011, 928 and 1241 were
maintained in RPMI 1640 medium containing 5%
bovine calf serum, 2 mM L-glutamine, and 10 mM
HEPES, pH 7.5, under standard tissue culture con-
ditions. Cells were treated with ALLnL when in ex-
ponential growth.
2.3. Immunoprecipitation and immunoblotting
Cells were treated for 6 h with 100 WM ALLnL,
washed twice in ice-cold phosphate-bu¡ered saline
(PBS), and incubated with ice-cold Triton X-100 lysis
bu¡er (Tris^HCl, pH 8, 20 mM; Triton X-100, 1%;
NaCl, 140 mM; glycerol, 10%; EGTA, 1 mM;
MgCl2; 1.5 mM; dithiothreitol, 1 mM; sodium van-
adate, 1 mM; NaF, 50 mM) [17] containing 1 mM
PMSF, 20 Wg/ml leupeptin and 20 Wg/ml aprotinin.
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Cells were scraped after 15 min and cell lysates were
clari¢ed by centrifugation (at 4‡C) at 14 000Ug for
30 min. Pellet samples, which represent the Triton X-
100-insoluble fraction, were separated from the
supernatant, representing the Triton X-100-soluble
fraction, resuspended in lysis bu¡er, sonicated twice
for 10 s at 4‡C, and equalized by protein to the
soluble fraction samples. Protein concentration of
each fraction was determined by the BCA assay us-
ing bovine serum albumin as standard. L-Catenin
was immunoprecipitated from cell lysates with 1 Wg
of anti-L-catenin antibody, followed by rabbit anti-
mouse IgG1 previously bound to protein A-Sephar-
ose beads. The immunoadsorbed pellets were washed
¢ve times with Triton X-100 lysis bu¡er and heated
to 95‡C in 1Ureducing Laemmli loading bu¡er. Ali-
quots of cell lysates diluted in 5Ureducing loading
bu¡er, and immunoprecipitates, were fractionated by
10% SDS^PAGE and electrotransferred to Protran
nitrocellulose membranes. Western blotting was per-
formed as previously described [34]. Proteins were
visualized by chemiluminescence using a commercial
kit. X-OMAT AR ¢lms (Kodak) were scanned into a
computer, and the images were quanti¢ed using im-
age analysis software (NIH Image).
2.4. Cytoskeletal localization of L-catenin
To detect cytoskeleton-associated L-catenin by im-
muno£uorescence [35], melanoma cells, grown on
sterile coverslips, were washed with PHEM bu¡er
(PIPES, 60 mM; HEPES, 25 mM; MgCl2; 2 mM;
EGTA, pH 6.9, 10 mM), permeabilized with Triton
X-100 (1%, in PHEM bu¡er) for 2 min, and ¢xed
with 3.7% formaldehyde in PBS for 10 min at room
temperature. Non-speci¢c binding sites were then
blocked by incubating the coverslips with 1% bovine
serum albumin in PBS for 1 h at 4‡C before process-
ing for immuno£uorescence labeling. Primary anti-
body was added to the coverslips and incubated for
1 h at 4‡C. After antibody incubation, coverslips
were washed two times for 2 min with PBS and in-
cubated at 4‡C for 1 h with Cy3-conjugated goat
anti-mouse immunoglobulin (Jackson Immuno-Re-
search Laboratories, Inc.). To detect total endoge-
nous L-catenin, melanoma cells grown on coverslips
were washed with 1UPBS, immediately ¢xed with
3.7% formaldehyde in PBS for 10 min at room tem-
perature, rinsed with PBS, and permeabilized with
0.2% Triton X-100 (in PBS) for 10 min at room
temperature. Cells were then blocked and stained
as described above for the cytoskeletal preparation.
After staining, the coverslips were washed with PBS,
rinsed quickly with water, air-dried, and mounted
onto slides using SlowFade solution (Molecular
Probes). Fluorescence was visualized using a Zeiss
Axioskop microscope and an Optronics CCD cam-
era.
2.5. Microsomal fractionation
Exponentially growing melanoma cells exposed to
100 WM ALLnL for 6 h were washed twice in ice-
cold PBS and incubated with ice-cold lysis bu¡er
without Triton X-100 for 30 min. Total cell lysates
were immediately sonicated twice and centrifuged at
5000 rpm for 5 min. Supernatant was transferred
into an ultracentrifuge glass tube, while the pellet,
representing the membrane and nuclear fraction,
was resuspended in lysis bu¡er without detergent
and sonicated again. The low speed supernatant
was centrifuged at 100 000Ug at 4‡C for 60 min.
The high speed supernatant, representing the cyto-
solic fraction, was separated from the pellet, repre-
senting the microsomal fraction, which was resus-
pended in lysis bu¡er without detergent and
sonicated. All three fractions were equalized for pro-
tein. L-Catenin was immunoprecipitated from each
fraction and detected by Western blot as described
above. Band density for both control and ALLnL-
treated samples was analyzed by NIH Image and
graphically expressed as a percentage of each control.
2.6. Preparation of isolated nuclei and DNase
treatment
Intact nuclei were obtained from exponentially
growing melanoma cells treated with 100 WM
ALLnL for 6 h. Melanoma cells were scraped in
nuclei isolation bu¡er (NaCl, 100 mM; Tris^HCl,
10 mM; sodium butyrate, 5 mM, iodoacetamide,
10 mM; 0.1% NP-40; PMSF, 1 mM) containing 20
Wg/ml leupeptin and 20 Wg/ml aprotinin, and gently
homogenized in an ice-cold glass homogenizer. A
cytosolic fraction (supernatant) was separated from
intact nuclei (pellet) by low speed centrifugation at
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4‡C for 10 min. Intact nuclei, observed by staining
with trypan blue, were lysed either in 1ULaemmli
loading bu¡er (containing SDS) to yield a total nu-
clear preparation, or in TNESV lysis bu¡er (Tris^
HCl, pH 7.5, 50 mM; 1% NP-40; EDTA, 2 mM;
NaCl, 100 mM; orthovanadate, 10 mM) on ice for
30 min. In the latter case, the NP40-soluble nuclear
fraction (supernatant) was separated from the NP40-
insoluble nuclear fraction by high speed centrifuga-
tion at 4‡C for 30 min. The detergent-insoluble pellet
was then resuspended in TNESV bu¡er by sonica-
tion at 4‡C. Immunoprecipitations (using 200 Wg of
protein) and Western blotting were performed as de-
scribed. To digest double-stranded DNA, detergent-
insoluble nuclear extracts were incubated in DNase I
digestion bu¡er (Tris^HCl pH 7.9, 40 mM; NaCl, 10
mM; MgCl2, 6 mM; CaCl2, 10 mM) with 100 U of
RQ1 RNase-free DNase (Promega) at 37‡C for 30
min. The remaining insoluble fraction (pellet), repre-
senting nuclear matrix elements and digested DNA,
was separated from soluble material (supernatant) by
high speed centrifugation at 4‡C for 30 min. L-Cat-
enin released into the soluble fraction by DNase
treatment was analyzed by Western blotting.
2.7. Transient transfections
To determine speci¢c e¡ects of nuclear accumula-
tion of L-catenin on TCF-dependent transcription,
melanoma cells were transiently transfected with
the reporter constructs pTOPFLASH and pFOP-
FLASH, which contain, respectively, three copies
of the optimal (CCTTTGATC), or mutant (CCTT-
TGGCC), TCF binding motif upstream of a minimal
c-Fos promoter driving luciferase expression [28].
For the transient transfection experiment shown in
Fig. 4C, 1 Wg of the reporter was transfected into 928
or 1241 cells (1U106 cells for each cell line) using
lipofectamine, according to the manufacturer’s in-
structions (Gibco-BRL). To avoid non-speci¢c,
drug-dependent e¡ects on luciferase expression, and
to control for transfection e⁄ciency, we performed a
DUAL-Luciferase reporter assay (Promega). A con-
trol reporter, pRL-TK (0.25 Wg), which contains a
herpes simplex virus thymidine kinase promoter driv-
ing a Renilla luciferase gene, was co-transfected with
the L-catenin/TCF-speci¢c luciferase constructs, and
Renilla luciferase activity was used to normalize the
data. After 24 h, cells were lysed in Triton X-100
lysis bu¡er and luciferase activities were monitored
in 30 Wg of cell lysate using DUAL-Luciferase assay
reagents as described by the manufacturer (Prome-
ga). Melanoma cells treated with 100 WM ALLnL
were exposed to the proteasome inhibitor for the
¢nal 6 h before lysing.
3. Results
3.1. E¡ect of proteasome inhibition on
detergent-insoluble L-catenin
Three previously described melanoma cell lines
[17] have been used in this study: 1241 expresses
APC, but the L-catenin in these cells carries a
Ser37CPhe37 (S37F) substitution in the GSK-3L
Fig. 1. ALLnL increases L-catenin steady-state level in a detergent-insoluble fraction. (A) Detergent-soluble fractions. Exponentially
growing 1011, 928 and 1241 melanoma cells were cultured for 6 h without (3) and with (+) 100 WM ALLnL. L-Catenin was immuno-
precipitated from 200 Wg of detergent-soluble 1011 cell lysate (lanes 1 and 2), and from 100 Wg of detergent-soluble lysate from 928
(lanes 3 and 4) and 1241 (lanes 5 and 6) cells. Proteins were resolved by reducing 10% SDS^PAGE, electrotransferred to nitrocellulose
membranes, and probed for L-catenin. (B) Detergent-insoluble fractions. Anti-L-catenin immunoblots of L-catenin immunoprecipitates
were performed from detergent-insoluble fractions of untreated (3) and 6-h ALLnL-treated (+) 1011 (lanes 7 and 8), 928 (lanes 9 and
10) and 1241 (lanes 11 and 12) cells as described in Section 2.
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phosphorylation site; 928 expresses wild type L-cat-
enin but no detectable APC; 1011 contains both wild
type L-catenin and APC. Melanoma cells were
treated with the proteasome inhibitor ALLnL (100
WM) [36,37] for 6 h. As shown in Fig. 1A, Triton X-
100-soluble L-catenin in both 1241 and 928 is resis-
tant to proteasome-mediated degradation, as re-
ported previously [14]. As expected, proteasome sen-
sitivity of the detergent-soluble protein was seen only
in 1011 cells. However, when L-catenin from Triton
X-100-insoluble fractions was examined, sensitivity
to proteasome inhibition was seen in all three cell
lines (Fig. 1B). Similar results were obtained with
the highly speci¢c proteasome inhibitor lactacystin
(data not shown).
3.2. Subcellular distribution of L-catenin following
proteasome inhibition
We next examined the e¡ect of proteasome inhibi-
tion on L-catenin steady-state levels in soluble, mi-
crosomal and particulate fractions after detergent-
free cell lysis and fractionation. Log-phase melanoma
cells were exposed to ALLnL (100 WM) for 6 h, re-
moved from the culture dishes by scraping, and re-
suspended in detergent-free lysis bu¡er (see Section
Fig. 2. Analysis of L-catenin by detergent-free subcellular fractionation. Untreated (E, 3) and 100 WM ALLnL-treated (F, +) melano-
ma cells were fractionated under detergent-free conditions into soluble (s), microsomal (m) and particulate (p) fractions, as described
in Section 2. L-Catenin was immunoprecipitated from each fraction and measured by Western blot, as described in Fig. 1. In panel A,
data are expressed as folds above untreated samples. In panel B, data are expressed as a fraction of the total L-catenin found in each
subcellular compartment.
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2). After sonication, soluble, microsomal and partic-
ulate (cytoskeleton/nuclear matrix) fractions were
prepared. All fractions were then solubilized, sepa-
rated by SDS^PAGE, and immunoblotted for L-cat-
enin. As shown in Fig. 2A, the L-catenin steady-state
level in 1011 cells was increased primarily in the
soluble fraction, and to a lesser extent in the partic-
ulate fraction following ALLnL treatment. In con-
trast, in 928 and 1241 cells, L-catenin protein mark-
edly accumulated only in the particulate fraction
after proteasome inhibition.
L-Catenin content of the microsomal fraction,
which represents membrane-associated L-catenin, re-
mained una¡ected by proteasome inhibition in all
cell lines. In fact, the amount of L-catenin co-immu-
noprecipitated with E-cadherin was not altered in
any of the three cell lines by ALLnL treatment
(data not shown). These data support the hypothesis
that the microsomal pool of L-catenin is resistant to
proteasome-mediated degradation [11,12].
By comparing the fraction of total L-catenin con-
tained within each subcellular compartment (Fig.
2B), our current data reveal that in 1011 cells, which
express both wild type L-catenin and APC, the bulk
of L-catenin normally resides in the microsomal frac-
tion, with comparatively little found in the soluble
Fig. 3. Stabilized L-catenin accumulates in the nuclei of melanoma cells after ALLnL treatment. 1011 (A^B, G^H), 928 (C^D, I^J)
and 1241 (E^F, K^L) cells, grown on coverslips, were treated with ALLnL (100 WM) for 6 h. Cytoskeleton-associated L-catenin (A^F)
and total cellular L-catenin (G^L) were detected by immuno£uorescence as described in Methods. Panels A, C, E, G, I and K repre-
sent untreated melanoma cells. Panels B, D, F, H, J and L represent ALLnL-treated cells.
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fraction (white bars). However, the proportions
change dramatically upon proteasome inhibition, so
that soluble L-catenin becomes the predominant
component (black bars). In contrast, in the two mel-
anoma cell lines with aberrant regulation of L-cate-
nin, the soluble component is most abundant in un-
treated cells (white bars), as expected, but the relative
concentration of L-catenin in this fraction actually
decreases upon proteasome inhibition (black bars),
due to the large increase of L-catenin in the partic-
ulate fraction. The data in Fig. 2B demonstrate that
the particulate component of L-catenin displays
APC- and GSK-3L-independent proteasome sensitiv-
ity.
3.3. Nuclear localization of detergent-insoluble,
proteasome-sensitive L-catenin
The particulate fraction from the previous experi-
ment contains primarily DNA, the cellular cytoskel-
etal network, and nuclear matrix. We next wished to
determine more precisely the subcellular location of
Fig. 4. ALLnL increases L-catenin steady-state in chromatin and nuclear matrix fractions. (A) 1011 and 928 cells were treated with
100 WM ALLnL for 6 h, cells were homogenized, intact nuclei were isolated from cytosol (C), and total nuclear preparations (N) were
obtained as described in Section 2. L-Catenin was measured in 40 Wg of each fraction by Western blot. Membranes were re-probed
with antibody to K-tubulin to verify the purity of the nuclear preparations. (B) 1011 (lanes 1^6), 928 (lanes 7^12) and 1241 (lanes 13^
18) cells were cultured for 6 h with (+) or without (3) 100 WM ALLnL. Cells were homogenized and intact nuclei were isolated from
cytosol, lysed with NP40-containing bu¡er and separated into detergent-soluble and -insoluble fractions, as described in Section 2.
L-Catenin was precipitated from 100 Wg of each subcellular fraction and measured by Western blot. (C) Distribution of nuclear L-cate-
nin after DNase treatment. Exponentially growing 928 cells were cultured with (+) or without (3) 100WM ALLnL for 6 h and intact
nuclei were prepared as described in Section 2. The nuclear detergent-insoluble fraction was incubated with 100 U of RQ1 RNase-free
DNase at 37‡C for 30 min. Resultant soluble and insoluble fractions were separated by high speed centrifugation, and L-catenin was
precipitated from 100 Wg of each fraction and measured by Western blot.
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this L-catenin pool. Melanoma cells growing on cov-
erslips were treated with ALLnL (100 WM) for 6 h.
The coverslips were then treated to remove soluble
and loosely associated membrane proteins (see Sec-
tion 2). The resultant cytoskeletal preparations were
immunostained with anti-L-catenin antibody and vi-
sualized by £uorescence microscopy (Fig. 3). Nuclei
were localized by double-staining each cell prepara-
tion with the DNA dye DAPI (data not shown).
Strong accumulation of primarily nuclear cytoskele-
ton-associated L-catenin in 1011 and 1241 cells can
be seen following ALLnL treatment (compare panels
A and B, and E and F, respectively). Although the
nuclear signal also clearly increased in 928 cells, un-
treated cells displayed detectable amounts of nuclear
cytoskeleton-associated L-catenin as well (compare
panels C and D). For comparison, L-catenin immu-
no£uorescence in whole cell preparations is also
shown (Fig. 3G^L). In these analyses, soluble L-cat-
enin pools are also visualized. Although nuclear ac-
cumulation is seen in 1011 cell preparations follow-
ing proteasome inhibition (compare panels G and
H), L-catenin distribution in 928 and 1241 cells is
di¡use and una¡ected by ALLnL. Elevated nuclear
localization of L-catenin in the cytoskeleton prepara-
tions of proteasome-inhibited cells observed by im-
muno£uorescence microscopy was con¢rmed by con-
focal analysis of the same specimens (data not
shown). From these data, we can conclude that a
signi¢cant portion of the detergent-insoluble, partic-
ulate pool of L-catenin which retains APC- and
GSK-3L-independent proteasome sensitivity resides
in the nucleus in association with nuclear cytoskeletal
components.
In order to con¢rm and extend the immuno£uo-
rescence results, we isolated intact nuclei from cyto-
sol before and after proteasome inhibition. In the
¢rst experiment, we veri¢ed that our nuclei isolation
method resulted in nuclear preparations not conta-
minated with cytosolic proteins (by probing blots of
total nuclear fractions (see Section 2) with antibody
to K-tubulin), and that proteasome inhibition in-
creased L-catenin in the nuclear fraction (Fig. 4A).
Next, we measured L-catenin steady-state level in cy-
tosolic, nuclear NP40-soluble and nuclear NP40-in-
soluble fractions (Fig. 4B). Cytosolic and nuclear
soluble L-catenin was elevated by ALLnL only in
1011 cells. In 928 and 1241 cells, these fractions re-
mained unresponsive to proteasome inhibition. In
contrast, the nuclear detergent-insoluble pool of
L-catenin increased markedly following proteasome
inhibition in both 928 and 1241 cells, and slightly
but detectably in 1011 cells.
3.4. Association of nuclear detergent-insoluble
L-catenin with chromatin
In order to determine if any of the detergent-in-
soluble fraction of nuclear L-catenin was bound to
chromatin, we incubated this fraction with DNase I
(see Section 2) and monitored the L-catenin released
into the supernatant. As shown in Fig. 4C, a signi¢-
cant percentage of nuclear detergent-insoluble L-cat-
enin of 928 melanoma cells can be solubilized by
DNase I treatment, suggesting its association with
chromatin. In agreement with these data, we ob-
served that L-catenin/TCF-responsive reporter activ-
ity (pTOPFLASH) in transiently transfected 928 and
1241 cells was increased following proteasome inhi-
bition, while activity of a reporter containing a mu-
Fig. 5. Proteasome inhibition results in increased L-catenin-driv-
en transcription in melanoma cells expressing stabilized L-cate-
nin. The TCF reporter constructs pTOPFLASH (wild type) or
pFOPFLASH (mutant) were transfected (1 Wg), using lipofect-
amine, into both 928 and 1241 cells, together with the Renilla
luciferase construct pRL-TK (0.25 Wg). After 18 h, ALLnL (100
WM) was added to some of the cells for an additional 6 h.
pTOPFLASH- and pFOPFLASH-dependent luciferase expres-
sion, normalized to Renilla luciferase expression (see Section 2),
were assayed 24 h after transfection using 30 Wg of total cell ly-
sate. Both cell lines demonstrate elevated L-catenin-dependent
reporter activity after proteasome inhibition.
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tated TCF binding site (pFOPFLASH) was unaf-
fected (Fig. 5). Since nuclear detergent-insoluble
L-catenin is the only subcellular pool a¡ected by pro-
teasome inhibition in both 928 and 1241 cell lines,
the data in Fig. 4C suggest an involvement of this
L-catenin component in modulating TCF-dependent
transcription.
4. Discussion
The current model of L-catenin function proposes
that L-catenin sensitivity to proteasomal degradation
requires both the presence of APC and an intact
GSK-3L phosphorylation site [11,13^15,17]. In this
study, we have identi¢ed a previously unrecognized
detergent-insoluble pool of L-catenin, primarily asso-
ciated with chromatin and nuclear cytoskeletal ele-
ments, which retains proteasome sensitivity inde-
pendent of APC status or GSK-3L phosphoryla-
tion. Although detergent-insoluble L-catenin nor-
mally comprises a relatively insigni¢cant portion of
the total cellular pool of the protein (2^5% in the
current experiments), following proteasome inhibi-
tion this proportion rises to 25^40%, irrespective of
APC status or L-catenin mutation. These ¢ndings
can perhaps be best appreciated by comparison of
L-catenin immuno£uorescence in intact and cytoskel-
etal preparations (Fig. 3). While analysis of intact
cells demonstrates elevated L-catenin-speci¢c £uores-
cence following proteasome inhibition only in 1011
cells, analysis of cytoskeletal preparations clearly re-
veals proteasome-sensitive nuclear accumulation of
L-catenin in all three cell lines. These results are con-
¢rmed by the subcellular fractionation studies also
presented.
Of what signi¢cance is the nuclear cytoskeletal
pool of L-catenin? At least a portion of this L-cate-
nin fraction can be solubilized by DNase treatment
and is thus chromatin-associated. Consistent with the
hypothesis that this fraction of the protein is tran-
scriptionally active, L-catenin-stimulated transcrip-
tional activity measured by transient transfection of
a TCF-dependent luciferase-based reporter construct
is also elevated following proteasome inhibition in
928 and 1241 cells. The only L-catenin pool to be
elevated by proteasome inhibition in these cells is
the nuclear cytoskeletal/chromatin fraction.
Although it has previously been proposed that nu-
clear accumulation of L-catenin is secondary to ac-
cumulation of the protein in the cytoplasm [12], our
data suggest the existence of a previously unrecog-
nized, rapidly turning over, nuclear cytoskeleton-as-
sociated pool of L-catenin. Unlike the soluble nuclear
and cytosolic pools of this protein, nuclear cytoskel-
eton-associated, detergent-insoluble L-catenin retains
its proteasome sensitivity even in the absence of APC
and with an S37F mutation in its GSK-3L phosphor-
ylation site. It is unlikely that the increased level of
nuclear detergent-insoluble L-catenin in proteasome-
inhibited 928 and 1241 cell lines derives from a cy-
toplasmic source since neither the nuclear soluble nor
cytosolic levels of L-catenin in these cells are altered
by proteasome inhibition. Due to its association with
a distinct set of nuclear proteins, detergent-insoluble
L-catenin may remain a substrate for nuclear protea-
somes independent of APC association or GSK-3L
phosphorylation. It is of interest to note in this re-
gard that immunohistochemical analysis of protea-
some distribution in the nucleus has detected these
multi-catalytic proteases in association with nuclear
cytoskeletal elements [38]. In summary, the localiza-
tion of L-catenin to the detergent-insoluble nuclear
fraction suggests this to be a physiologically impor-
tant L-catenin pool whose regulation appears to be
more complex than previously recognized.
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